{"schema_version":"secwatch.filing_event.v1","accession":"0001437749-25-028530","form_type":"8-K","ticker":"FLNA","cik":"0001069530","company_name":"FILANA THERAPEUTICS, INC.","filed_at":"2025-09-08T23:59:59+00:00","discovered_at":"2026-05-14T18:02:43.252558+00:00","generated_at":"2026-05-28T19:46:10.165598+00:00","sec_items":["7.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.25,"confidence":"low","headline":"Cassava Sciences files 8-K with corporate presentation; no specific facts extracted","bullets":["Company furnished a corporate presentation dated September 2025 as Exhibit 99.1.","Presentation is available on the Investors section of CassavaSciences.com.","No financial results, guidance, or business updates are disclosed in the filing."],"urls":{"canonical":"https://secwatch.observer/filing/0001437749-25-028530","json":"https://secwatch.observer/filing/0001437749-25-028530.json","markdown":"https://secwatch.observer/filing/0001437749-25-028530.md","text":"https://secwatch.observer/filing/0001437749-25-028530.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1069530/000143774925028530/0001437749-25-028530-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1069530/000143774925028530/sava20250904_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-28T19:46:10.165598+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}